A growing number of studies imply that CHES1 is tightly associated with tumor initiation and progression, and it is dysregulated in many types of carcinoma such as oral squamous cell carcinoma28, ovarian cancer29, colorectal cancer27,30, glioblastoma31, and hepatocellular carcinoma32. Here, FOXN3 is linked to carcinoma.